Pharma

Personalized Targeted Therapy Monitoring with Leading Edge Sensitivity

Detect 0-1 ctDNA Copy Transitions without False Negatives

  • Improve Detection of ctDNA (+) Samples at Landmark

  • Increase Lead Times on Response to Therapy, Resistance